Synergy between the KEAP1/NRF2 and PI3K Pathways Drives Non-Small-Cell Lung Cancer with an Altered Immune Microenvironment

Cited by (220)

Items 101–200 of 220

1. Kynureninase Upregulation Is a Prominent Feature of NFR2-Activated Cancers and Is Associated with Tumor Immunosuppression and Poor Prognosis
   Ricardo A. Léon-Letelier, Ali Hussein Abdel Sater, Yihui Chen, Soyoung Park, Ranran Wu, Ehsan Irajizad, Jennifer B. Dennison, Hiroyuki Katayama, Jody V. Vykoukal, Samir Hanash et al. · 2023 · Cancers
2. Prognostic and clinicopathological significance of NRF2 expression in non-small cell lung cancer: A meta-analysis
   Qingsong Wang, Liang Xu, Gang Wang, Lei Chen, Changping Li, Xiangli Jiang, Hai Gao, Bing Yang, Weiping Tian · 2020 · PLoS ONE
3. Anticancer natural products targeting immune checkpoint protein network
   Kyung‐Soo Chun, Do‐Hee Kim, Pawan Kumar Raut, Young‐Joon Surh · 2021 · Seminars in Cancer Biology
4. Energy metabolism as the hub of advanced non-small cell lung cancer management: a comprehensive view in the framework of predictive, preventive, and personalized medicine
   Ousman Bajinka, Serge Yannick Ouédraogo, Olga Golubnitschaja, Na Li, Xianquan Zhan · 2024 · The EPMA Journal
5. NRF2 Signaling Pathway in Chemo/Radio/Immuno-Therapy Resistance of Lung Cancer: Looking Beyond the Tip of the Iceberg
   Sri Vidya Ramisetti, Tapas Patra, Vinayak Munirathnam, Jyothi Venkat Sainath, Durgadevi Veeraiyan, Akhileshwar Namani · 2024 · Archivos de Bronconeumología
6. Nicotinic Acetylcholine Receptor Subunit α7 Mediates Cigarette Smoke-Induced PD-L1 Expression in Human Bronchial Epithelial Cells
   Hoi‐Hin Kwok, Boning Gao, Koon-Ho Chan, Msm Ip, John Dorrance Minna, David Chi-Leung Lam · 2021 · Cancers
7. Nuclear factor erythroid 2 (NF-E2)-related factor 2 (Nrf2) in non-small cell lung cancer
   Zhi Zeng, Ziyao Wang, Yukun Li, Dongmei Ye, Juan Zeng, Jiali Hu, Pi-feng Chen, Jiao Xiao, Juan Zou, Zhenhua Li · 2020 · Life Sciences
8. Simultaneous quantification of 26 NAD-related metabolites in plasma, blood, and liver tissue using UHPLC-MS/MS
   Hartmut Cuny, Esther Kristianto, Mark P. Hodson, Sally L. Dunwoodie · 2021 · Analytical Biochemistry
9. A CRISPR screen identifies redox vulnerabilities for KEAP1/NRF2 mutant non-small cell lung cancer
   Chang Jiang, Nathan P. Ward, Nicolas Prieto-Farigua, Yun Pyo Kang, Anish Thalakola, Mingxiang Teng, Gina M. DeNicola · 2022 · Redox Biology
10. Molecular Pathology of Pulmonary Large Cell Neuroendocrine Carcinoma: Novel Concepts and Treatments
    Masayo Yoshimura, Kurumi Seki, Andrey Bychkov, Junya Fukuoka · 2021 · Frontiers in Oncology
11. Effects of KRAS, STK11, KEAP1, and TP53 mutations on the clinical outcomes of immune checkpoint inhibitors among patients with lung adenocarcinoma
    Yao Liang, Osamu Maeda, Chiaki Kondo, Kazuki Nishida, Yuichi Ando · 2024 · PLoS ONE
12. Immunometabolism at the service of traditional Chinese medicine
    Herong Cui, Ji‐Yuan Zhang, Xue-Hao Cheng, Jiaxin Zheng, Qi Zhang, Rui Zheng, Liangzhen You, Dongran Han, Hongcai Shang · 2022 · Pharmacological Research
13. Targeting the cell signaling pathway Keap1-Nrf2 as a therapeutic strategy for adenocarcinomas of the lung
    Bo Zhang, Zhiyuan Ma, Biqin Tan, Nengming Lin · 2018 · Expert Opinion on Therapeutic Targets
14. Impact of Nuclear Factor Erythroid 2–Related Factor 2 in Hepatocellular Carcinoma: Cancer Metabolism and Immune Status
    Norifumi Iseda, Shinji Itoh, Tomoharu Yoshizumi, Takahiro Tomiyama, Akinari Morinaga, Kyohei Yugawa, Masahiro Shimokawa, Tomonari Shimagaki, Huanlin Wang, Takeshi Kurihara et al. · 2021 · Hepatology Communications
15. Distinct roles for the thioredoxin and glutathione antioxidant systems in Nrf2-Mediated lung tumor initiation and progression
    Amanda Sherwood, Basma A. Yasseen, Janine M. DeBlasi, Samantha Caldwell, Gina M. DeNicola · 2025 · Redox Biology
16. FGFR3-TACC3 is an oncogenic fusion protein in respiratory epithelium
    Sarah A. Best, Cassandra R. Harapas, Ariena J. Kersbergen, Vivek Rathi, Marie-Liesse Asselin-Labat, Kate D. Sutherland · 2018 · Oncogene
17. Ganoderma lucidum polysaccharide promotes broiler health by regulating lipid metabolism, antioxidants, and intestinal microflora
    Yu-Yun Gao, Ying-Huan Zhou, Xiao-Ping Liu, Bin Di, Jiayi He, Yating Wang, Pingting Guo, Jing Zhang, Changkang Wang, Ling Jin · 2024 · International Journal of Biological Macromolecules
18. Comprehensive Analysis Identifies PI3K/Akt Pathway Alternations as an Immune-Related Prognostic Biomarker in Colon Adenocarcinoma Patients Receiving Immune Checkpoint Inhibitor Treatment
    Anqi Lin, Tianqi Gu, Xigang Hu, Jian Zhang, Peng Luo · 2022 · Journal of Immunology Research
19. Consequences of Zmat3 loss in c-MYC- and mutant KRAS-driven tumorigenesis
    Sarah A. Best, Cassandra J. Vandenberg, Etna Abad, Lachlan W. Whitehead, Laia Guiu, Sheryl Ding, Margs S. Brennan, Andreas Strasser, Marco J. Herold, Kate D. Sutherland et al. · 2020 · Cell Death and Disease
20. MEScan: a powerful statistical framework for genome-scale mutual exclusivity analysis of cancer mutations
    Sisheng Liu, Jinpeng Liu, Yanqi Xie, Tingting Zhai, Eugene W. Hinderer, Arnold J. Stromberg, Nathan L. Vanderford, Jill Kolesar, Hunter Moseley, Li Chen et al. · 2020 · Bioinformatics
21. The Complex Roles of Redox and Antioxidant Biology in Cancer
    Makiko Hayashi, Keito Okazaki, Thales Papgiannakopoulos, Hozumi Motohashi · 2024 · Cold Spring Harbor Perspectives in Medicine
22. Of Context, Quality, and Complexity: Fine-Combing Tumor Mutational Burden in Immunotherapy-Treated Cancers
    Noushin Niknafs, Mimi Najjar, Colum Dennehy, Ioannis Stouras, Valsamo Anagnostou · 2025 · Clinical Cancer Research
23. Targeting Ferroptosis as an Advance Strategy in Cancer Therapy
    Tobias Achu Muluh, Qianqian Fu, Xiaojiao Ai, Changfeng Wang, Wei Chen, Xiangyi Zheng, Wei Wang, Maolin Wang, Xing‐sheng Shu, Ying Ying · 2024 · Antioxidants and Redox Signaling
24. De novo NAD synthesis is required for intracellular replication of Coxiella burnetii, the causative agent of the neglected zoonotic disease Q fever
    Mebratu A. Bitew, Chen Ai Khoo, Nitika Neha, David Peter De Souza, Dedreia Tull, Nadeeka K. Wawegama, Hayley J. Newton, Fiona M. Sansom · 2018 · Journal of Biological Chemistry
25. Development of targeted therapy of NRF2high esophageal squamous cell carcinoma
    Chorlada Paiboonrungruang, Emily Simpson, Zhaohui Xiong, Caizhi David Huang, Jianying Li, Yahui Li, Xiaoxin Luke Chen · 2021 · Cellular Signalling
26. Creatine riboside is a cancer cell–derived metabolite associated with arginine auxotrophy
    Amelia L. Parker, Leila Toulabi, Takahiro Oike, Yasuyuki Kanke, Daxeshkumar Patel, Takeshi Tada, Sheryse Taylor, Jessica A. Beck, Elise D. Bowman, Michelle L. Reyzer et al. · 2022 · Journal of Clinical Investigation
27. The Impact of TP53-Induced Glycolysis and Apoptosis Regulator on Prognosis in Hepatocellular Carcinoma: Association with Tumor Microenvironment and Ferroptosis
    Katsuya Toshida, Shinji Itoh, Norifumi Iseda, Shugo Tanaka, Kensuke Nakazono, Takahiro Tomiyama, Shohei Yoshiya, Takeo Toshima, Noboru Harada, Kenichi Kohashi et al. · 2024 · Liver Cancer
28. PILAR1, a novel prognostic LncRNA, reveals the presence of a unique subtype of lung adenocarcinoma patients with KEAP1 mutations
    Pranjal Kumar, Seema Khadirnaikar, Sudhanshu Kumar Shukla · 2019 · Gene
29. Comparison of COVID-19 and Lung Cancer via Reactive Oxygen Species Signaling
    Zilan Zhu, Ziyi Zheng, Jian Liu · 2021 · Frontiers in Oncology
30. The Expression of TP53-Induced Glycolysis and Apoptosis Regulator (TIGAR) Can Be Controlled by the Antioxidant Orchestrator NRF2 in Human Carcinoma Cells
    Helga Simon‐Molas, Cristina Sánchez‐de‐Diego, Àurea Navarro‐Sabaté, Esther Castaño, Francesc Ventura, Ramón Bartrons, Ànna Manzano · 2022 · International Journal of Molecular Sciences
31. Cellular Nrf2 Levels Determine Cell Fate during Chemical Carcinogenesis in Esophageal Epithelium
    Makoto Horiuchi, Keiko Taguchi, Wataru Hirose, Kouhei Tsuchida, Mikiko Suzuki, Yusuke Taniyama, Takashi Kamei, Masayuki P. Yamamoto · 2020 · Molecular and Cellular Biology
32. [Retracted] Homeobox A1 Facilitates Immune Escape and Alleviates Oxidative Stress in Lung Adenocarcinoma
    Fen Zhao, Hui Tian, Xinchao Liu, Yuanxiazi Guan, Ying Yan Zhu, Peng Ren, Jianbo Zhang, Yinjun Dong, Lei Fu · 2022 · Oxidative Medicine and Cellular Longevity · Retracted
33. AMPK-Mediated Phosphorylation of Nrf2 at S374/S408/S433 Favors Its βTrCP2-Mediated Degradation in KEAP1-Deficient Cells
    Eleni Petsouki, Sylvia Ender, Shara Natalia Sosa Cabrera, Elke H. Heiß · 2023 · Antioxidants
34. Protective effect of dexmedetomidine against delayed bone healing caused by morphine via PI3K/Akt mediated Nrf2 antioxidant defense system
    Yani Lou, Linfang Zou, Zhenyu Shen, Jianwei Zheng, Yuanqu Lin, Zhe Zhang, Xuankuai Chen, Jun Pan, Xutong Zhang · 2024 · Frontiers in Pharmacology
35. FXR1 facilitates axitinib resistance in clear cell renal cell carcinoma via regulating KEAP1/Nrf2 signaling pathway
    Haipeng Huang, Jiange Zhang, Peng Jiang, Xiaolong Xu, Fu Huang, Binli Zhao, Xiaoming Wang, Liquan Zhou · 2022 · Anti-Cancer Drugs
36. Role of NRF2 in immune modulator expression in developing lung
    Ritu Mishra, Afshan Fathima Nawas, Carole R. Mendelson · 2021 · The FASEB Journal
37. Exploring How Reactive Oxygen Species Contribute to Cancer via Oxidative Stress
    Alireza Tavakolpournegari, Seyedeh Safoora Moosavi, Arash Matinahmadi, Zoofa Zayani, Seyed Hesamoddin Bidooki · 2025 · Stresses
38. SdrA, an NADP(H)‐regenerating enzyme, is crucial for Coxiella burnetii to resist oxidative stress and replicate intracellularly
    Mebratu A. Bitew, Janine Hofmann, David Peter De Souza, Nadeeka K. Wawegama, Hayley J. Newton, Fiona M. Sansom · 2019 · Cellular Microbiology
39. Exploring natural killer cell immunology as a therapeutic strategy in lung cancer
    Jonas B. Hess, Kate D. Sutherland, Sarah A. Best · 2021 · Translational Lung Cancer Research
40. Absence of pro-survival A1 has no impact on inflammatory cell survival in vivo during acute lung inflammation and peritonitis
    Lahiru Gangoda, Robyn L. Schenk, Sarah A. Best, Christina Nedeva, Cynthia Louis, Damian B. D’Silva, Kirsten A. Fairfax, Andrew Jarnicki, Hamsa Puthalakath, Kate D. Sutherland et al. · 2021 · Cell Death and Differentiation
41. Effects of cyclic acute and chronic hypoxia on the expression levels of metabolism related genes in a pancreatic cancer cell line
    Nour Ali Obeidat, Malek Zihlif, Dana A. Alqudah, Walhan Alshaer, Moath Alqaraleh, Shtaywy Abdalla · 2022 · Biomedical Reports
42. Identification of the Key miRNAs and Genes Associated with the Regulation of Non-Small Cell Lung Cancer: A Network-Based Approach
    Zoya Shafat, Mohd Murshad Ahmed, Fahad Nasser Almajhdi, Tajamul Hussain, Shama Parveen, Anwar Ahmed · 2022 · Genes
43. NRF2 activation in cancer and overview of NRF2 small molecule inhibitors
    Hoang Hai Ngo, Bo-Yeong Yu, Jeong‐Eun Lee, Hyun Woo Kim, Young‐Sam Keum · 2025 · Archives of Pharmacal Research
44. KRAS-targeted therapies in cancer: novel approaches and overcoming resistance
    Daolin Tang, Guido Kroemer, Rui Kang · 2025 · BMJ Oncology
45. NRP1 overexpression potentially enhances osimertinib resistance in NSCLC via activation of the PI3K/AKT signaling pathway
    Yiping Wang · 2024 · American Journal of Cancer Research
46. Untangling the KRAS mutated lung cancer subsets and its therapeutic implications
    Ritu Kulshrestha, Pawan Kumar, Amit Singh, K. Nupur, Sonam Spalgias, Parul Mrigpuri, Rajkumar · 2021 · Molecular Biomedicine
47. Histone lysine methyltransferase SETDB2 suppresses NRF2 to restrict tumor progression and modulates chemotherapy sensitivity in lung adenocarcinoma
    Guangda Yuan, Bowen Hu, Jun Ma, Chuanyu Zhang, Hongya Xie, Tengteng Wei, Yong Yang, Bin Ni · 2022 · Cancer Medicine
48. Overcoming resistance to immune checkpoint inhibitor in non-small cell lung cancer: the promise of combination therapy
    Xuebing Shi, Wenxia Deng, Yunlei Pan, Yingchun Chen, Yinke Wang, Jing Wu · 2025 · Frontiers in Immunology
49. Trans-Ancestry Mutation Landscape of Hepatoblastoma Genomes in Children
    Jie Liu, Chengwen Gao, Liping Wang, Xuemin Jian, Mingdi Ma, Tong Li, Xiwei Hao, Qian Zhang, Yuanbin Chen, Jing Zhao et al. · 2021 · Frontiers in Oncology
50. La Alhambra de Leopoldo Torres Balbás : obras de restauración y conservación, 1923-1936
    Carlos Vílchez Vílchez · 1988 · Dialnet (Universidad de la Rioja)
51. Remodeling of Carbon Metabolism during Sulfoglycolysis in Escherichia coli
    Janice W.-Y. Mui, David Peter De Souza, Eleanor C. Saunders, Malcolm John McConville, Spencer John Williams · 2023 · Applied and Environmental Microbiology
52. Prevalence and Associations of Co-occurrence of NFE2L2 Mutations and Chromosome 3q26 Amplification in Lung Cancer
    Jinfeng Liu, Sijie Liu, Dan Li, Hongbin Li, Fan Zhang · 2024 · Global Medical Genetics
53. Reductive stress in cancer immunology and targeted therapy
    Xiaotian Ji, Gang Xiao · 2025 · Acta Biochimica et Biophysica Sinica
54. Cancer inhibition mechanism of lung cancer mouse model based on dye trace method
    Wei Zhang, Hongyan Shu, Lixin Fang, Ning Tang, Yucai Li, Bingrong Guo, Fanhui Meng · 2020 · Saudi Journal of Biological Sciences
55. Bioinformatics prediction of differential miRNAs in non-small cell lung cancer
    Kui Xiao, Shenggang Liu, Yijia Xiao, Yang Wang, Zhiruo Zhu, Yaohui Wang, De Tong, Jiehan Jiang · 2021 · PLoS ONE
56. KEAP1-Mutant Lung Cancers Weaken Anti-Tumor Immunity and Promote an M2-like Macrophage Phenotype
    Christopher John Occhiuto, Karen T. Liby · 2024 · International Journal of Molecular Sciences
57. Development and validation of matrix metalloproteinase for predicting prognosis and tumour microenvironment immune profiles in uterine corpus endometrial carcinoma
    Huancheng Su, Yutong Yang, Chu Li, Jinpeng Li, Huihui Lv, Xiaoyao Jia, Jiaolin Yang, Jing Lei, Xia Li, Hongrui Guo et al. · 2024 · Journal of Cancer
58. Cancer mutation profiles predict ICIs efficacy in patients with non-small cell lung cancer
    Liping Zhu, Dafu Ye, Tianyu Lei, Jie Wu, Wei Wang, Bin Xu · 2022 · Expert Reviews in Molecular Medicine
59. Local burn wound environment versus systemic response: Comparison of proteins and metabolites
    Tuo Zang, Kiana Heath, Joseph Etican, Lan Chen, Donna Langley, Andrew J. A. Holland, Lisa J Martin, Mark William Fear, Tony J. Parker, Roy Mark Kimble et al. · 2022 · Wound Repair and Regeneration
60. Mechanisms and Markers of Clinical Radioresistance
    Michael Sargent Binkley, Maximilian Diehn, Iris Eke, Henning Willers · 2020 · Cancer drug discovery and develogment/Cancer drug discovery and development
61. Prognostic values of the immune microenvironment-related non-coding RNA IGF2BP2-AS1 in bladder cancer
    Ke Ding, Zhihuan Zheng, Yu Han, Xiangyun Huang · 2022 · Cell Cycle
62. Intratumor heterogeneity of driver mutations and TMB distribution in 30 early-stage LUAD patients with multiple lesions
    Yuan Qiu, Liping Liu, Haihong Yang, Hanzhang Chen, Qiuhua Deng, Dakai Xiao, Yongping Lin, Changbin Zhu, Weiwei Li, Ди Шао et al. · 2022 · Frontiers in Oncology
63. Redox phenotype confers T cell-exclusion microenvironment and resistance to immunotherapy by suppressing STING/MDA5 expression and interferon signaling in lung cancers harboring KEAP1/STK11 mutations
    Ziying Lin, Shrestha Ashish, Lixia Huang, Shaoli Li, Yangchan Li, Yanbin Zhou, Jincui Gu · 2025 · Frontiers in Oncology
64. Single-Cell Kinetic Modeling of β-Lapachone Metabolism in Head and Neck Squamous Cell Carcinoma
    Andrew D. Raddatz, Cristina M. Furdui, Erik A. Bey, Melissa Lambeth Kemp · 2023 · Antioxidants
65. Phosphatase and Tensin Homolog Mutation in Immune Cell Infiltration and Clinicopathological Features of Low-Grade Gliomas
    Peng Feng, Zhenqing Li, Yuchen Li, Yuelin Zhang · 2020 · Frontiers in Molecular Biosciences
66. Limited role of KRAS mutation in guiding immunotherapy in advanced non-small-cell lung cancer
    Hong‐Shuai Li, Chengming Liu, Yan Wang · 2022 · Future Oncology
67. Nestin overexpression reduces the sensitivity of gastric cancer cells to trastuzumab
    Yichou Wei, Jiang-Yi Zhu, Jing Wu, Shan Yu, Wěi Li, Meng-Xuan Zhu, Tianshu Liu, Yuehong Cui, Qian Li · 2023 · Journal of Gastrointestinal Oncology
68. Studying the immune landscape in lung cancer models: choosing the right experimental tools
    Clare E. Weeden, Casey Ah-Cann, Marie-Liesse Asselin-Labat · 2018 · Translational Lung Cancer Research
69. Early immune pressure imposed by tissue resident memory T cells sculpts tumour evolution in non-small cell lung cancer
    Clare E. Weeden, Velimir Gayevskiy, Marie Trussart, Claire Marceaux, Nina Tubau Ribera, Daniel Batey, Charis E. Teh, Andrew John Mitchell, Phillip N. Antippa, Tracy L. Leong et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
70. First-Line Treatment of Driver-Negative Non–Small Cell Lung Cancer
    So Yeon Kim, Scott N. Gettinger · 2023 · Hematology/Oncology Clinics of North America
71. Papillary renal cell carcinoma with high‐ ABCC2 shows an immune‐evasive profile associated with favorable response to immunotherapy
    Vincent Francis Castillo, Abraam Zakhary, Fabio Rotondo, Caterina Di Ciano‐Oliveira, Malek Hamdani, Emelyn Adona, Theodorus van der Kwast, Kiril Trpkov, Rola Saleeb · 2025 · The Journal of Pathology
72. Tumor suppressor genes and KRAS G12C inhibitor resistance in non-small cell lung cancer
    Linsha Zhu, Xiangbo Jia, Lei Xu, Li Chen, Xiangning Fu, Hua Yan, Bo Ai, Shu Peng · 2025 · iScience
73. Overcoming Primary and Acquired Resistance to Immunotherapy in Non–Small Cell Lung Cancer: Mechanisms, Challenges, and Emerging Strategies
    Cassio Murilo Hidalgo-Filho, Valentina Santo, Eleonora Gariazzo, Mihaela D. Aldea, Federica Pecci, François‐Xavier Danlos, Gilberto de Castro Junior, Biagio Ricciuti · 2026 · Journal of Clinical Oncology
74. Exploration of ethnomedicinal plants of Western Himalayas used in the management of gastrointestinal disorders
    Ritika Dadhwal, Sakshi Sharma, Ritesh Banerjee · 2025 · Phytochemistry Reviews
75. Profiling changes in metabolism and the immune microenvironment in lung tumorigenesis
    Di Zhang, Ana S. Leal, Fawzi Abu Rous, Karen T. Liby · 2019 · Annals of Translational Medicine
76. The Keap1-Nrf2 Signaling Pathway in Lung Cancer
    Azhwar Raghunath, Nagarajan Raju, Kiruthika Sundarraj · 2021 · Springer eBooks
77. Flow Cytometry Identification of Cell Compartments in the Murine Brain
    Joel J D Moffet, Zachery Moore, Shannon J. Oliver, Tahnee Towers, Misty Rayna Jenkins, Saskia Freytag, James Richard Whittle, Sarah A. Best · 2023 · Methods in molecular biology
78. KEAP1-NFE2L2 Mutations in NSCLC: Increased Awareness Needed. Reply to “KEAP1-NFE2L2–Mutant NSCLC and Immune Checkpoint Inhibitors: A Large Database Analysis”
    Marco Mazzotta, Daniele Marinelli, Marcello Maugeri‐Saccà · 2020 · Journal of Thoracic Oncology
79. ACSM1 and ACSM3 regulate prostate cancer fatty acid metabolism to promote tumour growth and constrain ferroptosis
    Raj Kumar Shrestha, Zeyad D. Nassar, Adrienne R. Hanson, Richard D Iggo, Scott L. Townley, Jonas Dehairs, Chui Yan Mah, Madison Helm, Mohammadreza Alizadeh‐Ghodsi, Marie A. Pickering et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
80. HLA AND CANCER
    Александр Сергеевич Голота · 2021 · Physical and rehabilitation medicine medical rehabilitation
81. Whole brain radiation therapy resulting in radionecrosis: a possible link with radiosensitising chemoimmunotherapy
    Sam Ngu, Cassidy Werner, Randy S. D’ Amico, A. Gabriella Wernicke · 2023 · BMJ Case Reports
82. A new frontier in cancer therapy: The intersection of cancer vaccines and metabolomics
    Farah Ayman Sukareh, Ruba Al-Nemi, Peter Karagiannis, Hiba Nabil Asfour, Amita Verma, Mariusz Jaremko, Abdul-Hamid M. Emwas · 2024 · Elsevier eBooks
83. Heterogeneous expression of immunotherapy response markers in non-small cell lung cancer with hyperactive NRF2 pathway: PD-L1 and beyond
    Karoline Almeida, Marcelo Falchetti, Bárbara dos Santos, Marina Delgobo, Rosângela Mayer Gonçalves, Nauana Somensi, Helena Souza Zancanaro, Juan Nóbrega de Freitas, Raquel Nascimento das Neves, Lisléia Golfetto et al. · 2025 · Redox Biology
84. In vitro models of cancer‐associated fibroblast heterogeneity uncover subtype‐specific effects of CRISPR perturbations
    Elysia C. Saputra, Shamsudheen Karuthedath Vellarikkal, Lixia Li, Hong Sun, Khoa Dang P. Nguyen, Amber Montano, Suchitra Natarajan, Federica Piccioni, Alex M. Tamburino, Xin Yu et al. · 2025 · Molecular Oncology
85. The PI3K pathway is a downstream effector of NRF2 activation in the esophagus
    Boopathi Subramaniyan, Yahui Li, Zhaohui Xiong, Chorlada Paiboonrungruang, Candice Bui-Linh, Francis J. Spitz, Xiaoxin Luke Chen · 2025 · Translational Oncology
86. ANAIS DO II CONGRESSO INTERNACIONAL DE SAÚDE ÚNICA (INTERFACE MUNDIAL)
    2020
87. Precision medicine in immunotherapy and lung cancer
    Montse Sánchez‐Céspedes · 2023 · Anales de la Real Academia Nacional de Farmacia
88. NRF2 Participates in the Suppressive Tumor Immune Microenvironment of KRAS/KEAP1 Co-Mutant Non-Small Cell Lung Cancer by Inhibiting the STING Pathway
    Xiaodan Sun, Peiyan Zhao, Hui Li, Yan Liu, Ying Cheng · 2022 · Research Square
89. Study of the Role of NRF2 in the Progression and Metabolic Adaptation of Glioblastoma
    Maya M. Moubarak · 2024 · theses.fr (ABES)
90. Neuronal-specific function of hTim8a in Complex IV assembly provides insight into the molecular mechanism underlying Mohr-Tranebjærg syndrome
    Yilin Kang, Alexander James Anderson, David Peter De Souza, Catherine S. Palmer, Kenji Mark Fujihara, Tegan L. Stait, Ann E. Frazier, Nicholas James Clemons, Dedreia Tull, David Ross Thorburn et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
91. Integrated analysis of gene correlation reveals disordered relationship between metabolism and immunity in tumor microenvironment
    Zixi Chen, Jinfen Wei, Yuchen Yuan, Ying Cui, Yanyu Zhang, Yumin Hu, Hongli Du · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
92. Integrative omics analysis identifies subtypes with therapeutic implications in lung adenocarcinoma harboring KEAP1/NFE2L2
    Xiaodong Yang, Ming Li, Zhencong Chen, Liang Guo, Bo Jin, Yiwei Huang, Qun Wang, Liang Wu, Cheng Zhan · 2021 · Research Square
93. Drug Repurposing: An Avenue Toward Stress Medicine in Cancer Therapy
    Na Xie, Canhua Huang · 2021 · Springer eBooks
94. Genomics-based Precision Medicine for Patients with Cancer
    Joris van de Haar · 2021 · Utrecht University Repository (Utrecht University)
95. Modeling analysis of microenvironment of 3D cell mechanics based on machine vision
    Yuejin Zhang, Mengqiu Ye, Juan Wang, Guanghui Li, Meiling Zhong, Aiyun Zhan · 2022 · Open Physics
96. Multi-omics analysis identifies distinct subtypes with clinical relevance in lung adenocarcinoma harboring KEAP1/NFE2L2
    Xiaodong Yang, Ming Li, Zhencong Chen, Fan Xiaobin, Liang Guo, Bo Ram Jin, Yiwei Huang, Qun Wang, Liang Wu, Cheng Zhan · 2022 · Journal of Cancer
97. Single cell kinetic modeling of redox-based drug metabolism in head and neck squamous cell carcinoma
    Andrew D. Raddatz, Cristina M. Furdui, Erik A. Bey, Melissa Lambeth Kemp · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
98. Remodelling of carbon metabolism during sulfoglycolysis in Escherichia coli
    Janice W.-Y. Mui, David Peter De Souza, Eleanor C. Saunders, Malcolm John McConville, Spencer John Williams · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
99. Pan-cancer scale screening reveals NRF2 associated immunoevasive characteristics in non-small cell lung cancer and squamous malignancies
    Jouni Härkönen, Petri Pölönen, Ashik Jawahar Deen, Ilakya Selvarajan, Hanna‐Riikka Teppo, Elitsa Y. Dimova, Thomas Kietzmann, Maarit Ahtiainen, Tiia Eklund, Teijo Kuopio et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
100. Additional file 2 of Loss-of-function mutations in KEAP1 drive lung cancer progression via KEAP1/NRF2 pathway activation
     Meiling Gong, Li, Yan, Xiaoping Ye, Linlin Zhang, Zhifang Wang, Xiaowen Xu, Yejing Shen, Cuixia Zheng · 2020 · Figshare